Literature DB >> 32498278

Particle-Size-Dependent Delivery of Antitumoral miRNA Using Targeted Mesoporous Silica Nanoparticles.

Lisa Haddick1, Wei Zhang2, Sören Reinhard2, Karin Möller1, Hanna Engelke1, Ernst Wagner2, Thomas Bein1.   

Abstract

Multifunctional core-shell mesoporous silica nanoparticles (MSN) were tailored in size ranging from 60 to 160 nm as delivery agents for antitumoral microRNA (miRNA). The positively charged particle core with a pore diameter of about 5 nm and a stellate pore morphology allowed for an internal, protective adsorption of the fragile miRNA cargo. A negatively charged particle surface enabled the association of a deliberately designed block copolymer with the MSN shell by charge-matching, simultaneously acting as a capping as well as endosomal release agent. Furthermore, the copolymer was functionalized with the peptide ligand GE11 targeting the epidermal growth factor receptor, EGFR. These multifunctional nanoparticles showed an enhanced uptake into EGFR-overexpressing T24 bladder cancer cells through receptor-mediated cellular internalization. A luciferase gene knock-down of up to 65% and additional antitumoral effects such as a decreased cell migration as well as changes in cell cycle were observed. We demonstrate that nanoparticles with a diameter of 160 nm show the fastest cellular internalization after a very short incubation time of 45 min and produce the highest level of gene knock-down.

Entities:  

Keywords:  antitumoral microRNA (miRNA); cell targeting; confocal microscopy; core-shell; mesoporous silica nanoparticles; size-dependent delivery; surface functionalization

Year:  2020        PMID: 32498278     DOI: 10.3390/pharmaceutics12060505

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  7 in total

1.  Can increased expression of miR-Let-7c reduce the transition potential of high-grade urothelial carcinoma?

Authors:  Paulo Ricardo da Silva Gomes; Patricia Candido; Vitória Ghazarian; Juliana A Camargo; Vanessa R Guimarães; Guilherme L Gonçalves; Poliana Romão; Iran A Silva; Miguel Srougi; William C Nahas; Kátia R Leite; Sabrina T Reis; Ruan Pimenta; Nayara Izabel Viana
Journal:  Mol Biol Rep       Date:  2021-10-27       Impact factor: 2.316

Review 2.  Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications.

Authors:  Bazla Siddiqui; Asim Ur Rehman; Ihsan-Ul Haq; Amal A Al-Dossary; Abdelhamid Elaissari; Naveed Ahmed
Journal:  Int J Pharm X       Date:  2022-04-19

Review 3.  Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment.

Authors:  Eleen Dayana Mohamed Isa; Haslina Ahmad; Mohd Basyaruddin Abdul Rahman; Martin R Gill
Journal:  Pharmaceutics       Date:  2021-01-24       Impact factor: 6.321

Review 4.  Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy.

Authors:  Khaled AbouAitah; Witold Lojkowski
Journal:  Pharmaceutics       Date:  2021-01-22       Impact factor: 6.321

5.  Biosynthesis of gold nanoparticles for the treatment of osteoarthritis alone or in combination with Diacerein® in a rat model.

Authors:  Manal A Abdel-Aziz; Helmy M S Ahmed; Aziza A El-Nekeety; Hafiza A Sharaf; Sekena H Abdel-Aziem; Mosaad A Abdel-Wahhab
Journal:  Inflammopharmacology       Date:  2021-06-11       Impact factor: 4.473

Review 6.  Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects.

Authors:  Hui Zu; Danchen Gao
Journal:  AAPS J       Date:  2021-06-02       Impact factor: 4.009

7.  Resveratrol-Loaded Nanoemulsions: In Vitro Activity on Human T24 Bladder Cancer Cells.

Authors:  Federica Rinaldi; Linda Maurizi; Jacopo Forte; Massimiliano Marazzato; Patrizia Nadia Hanieh; Antonietta Lucia Conte; Maria Grazia Ammendolia; Carlotta Marianecci; Maria Carafa; Catia Longhi
Journal:  Nanomaterials (Basel)       Date:  2021-06-15       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.